| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.9M | +217.6% |
| Cost of Revenue | $19.1M | +1285.5% |
| Gross Profit | -$13.2M | -2800.1% |
| R&D Expense | $732K | +279.4% |
| SG&A Expense | $11.3M | +38.5% |
| Operating Income | -$38.7M | -388.4% |
| Pre-tax Income | -$39.1M | -342.2% |
| Income Tax | $0 | — |
| Net Income | -$39.1M | -342.2% |
| EPS (Basic) | -$11.54 | -1998.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $359K | -81.5% |
| Inventory | $0 | -100.0% |
| Current Assets | $3.5M | -80.2% |
| Total Assets | $4.7M | -85.7% |
| Current Liabilities | $13.3M | +13.1% |
| Long-term Debt | $486K | -85.6% |
| Total Liabilities | $13.6M | +15.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | -59.4% |
| Capital Expenditures | $177K | -58.9% |
| Investing Cash Flow | -$177K | +96.2% |
| Financing Cash Flow | $4.2M | -56.9% |
| Free Cash Flow | -$5.8M | -46.5% |
| -$8.9M |
| -142.7% |